Prothena

South San Francisco, United States

Prothena is a clinical-stage neuroscience company focused on the discovery and development of novel therapies.

$172.4M raised

Dec 2022

Post-IPO Equity

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Prothena raised?

Prothena has raised $172.4M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in December 2022.

Who are Prothena's investors?

Prothena's investors include Sofinnova Investments.

Where is Prothena headquartered?

Prothena is headquartered in South San Francisco, United States.

What does Prothena do?

Prothena is a clinical-stage neuroscience company focused on the discovery and development of novel therapies.

What stage is Prothena at?

Prothena is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 14, 2022.

MLA

"Prothena — Funding & Investors." VCBacked, December 14, 2022, https://www.vcbacked.co/company/prothena. Accessed July 2, 2026.

APA

VCBacked. (2022). Prothena — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/prothena

Wikipedia (cite web)

{{cite web |title=Prothena — Funding & Investors |url=https://www.vcbacked.co/company/prothena |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 14, 2022.